Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Granulocyte Transfusions for Neutropenic Patients with Perirectal and Perineal Infections

Darwin Roman, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Marina Y. Konopleva, MD PhD, Courtney D. DiNardo, MD MSc, Naval G. Daver, MD, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Steven M. Kornblau, MD, Prithviraj Bose, MD, Michael Andreeff, MD PhD, Emil J. Freireich, MD, Farhad Ravandi, MD, Fleur M. Aung, MD

Blood (2018) 132 (Supplement 1): 2544.

https://doi.org/10.1182/blood-2018-99-117895

Published: 2018

Journal Articles

Outcome of Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) By Age Group over 35 Years: A Single Institution Experience

Blood (2016) 128 (22): 3975.

https://doi.org/10.1182/blood.V128.22.3975.3975

Published: 2016

Journal Articles

Comparison of Two Apheresis Instruments (Old vs. New) for Granulocyte Collection: A Single Institutional Experience

Fleur M Aung, MD, Roland Bassett, Benjamin Lichtiger, MD PhD, Emil J. Freireich, MD

Blood (2016) 128 (22): 5036.

https://doi.org/10.1182/blood.V128.22.5036.5036

Published: 2016

Journal Articles

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV- mutated chronic lymphocytic leukemia

Philip A. Thompson, Constantine S. Tam, Susan M. O’Brien, William G. Wierda, Francesco Stingo, William Plunkett, Susan C. Smith, Hagop M. Kantarjian, Emil J. Freireich, Michael J. Keating

Blood (2016) 127 (3): 303–309.

https://doi.org/10.1182/blood-2015-09-667675

Published: 2016

Includes: Supplemental data

Journal Articles

Overall Survival in Hematopoietic Stem Cell Transplantation Is Not Correlated with Age of Red Cells Transfused Pre- and Post-Transplantation

Fleur M. Aung, MD, Roland L Bassett, MS, Benjamin Lichtiger, MDPhD, Emil J. Freireich, MD, Issa F Khouri

Blood (2014) 124 (21): 1213.

https://doi.org/10.1182/blood.V124.21.1213.1213

Published: 2014

Journal Articles

A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy

Courtney D. DiNardo, MD, Fleur M. Aung, MD, Fernando Martinez, MD MPH, Naval Daver, MD, Tapan Kadia, MD, Nitin Jain, MD, Elias Jabbour, MD, Naveen Pemmaraju, MD, Virgil M Reddy, MBBS, Guillermo Garcia-Manero, MD, Jorge Cortes, MD, Farhad Ravandi, MD, Hagop M. Kantarjian, MD, Benjamin Lichtiger, MDPhD, Emil J. Freireich, MD

Blood (2014) 124 (21): 1564.

https://doi.org/10.1182/blood.V124.21.1564.1564

Published: 2014

Journal Articles

Preventing Platelet Alloimmunization for Patients with Hematologic Malignancies: Rapid HLA-class I and HPA Immunogenetic Profiling to Enable Selection of Optimally Matched Platelets

Ghazala Hashmi, PhD, Dipika Patel, MS, Yi Zhang, Ph D, Michael Seul, Ph D, Fleur M. Aung, MD, Pedro Cano, MD, MBA, Emil J. Freireich, MD, Benjamin Lichtiger, MD, PhD

Blood (2012) 120 (21): 4691.

https://doi.org/10.1182/blood.V120.21.4691.4691

Published: 2012

Journal Articles

Twenty-five years of peripheral blood stem cell transplantation

Martin Körbling, Emil J Freireich

Blood (2011) 117 (24): 6411–6416.

https://doi.org/10.1182/blood-2010-12-322214

Published: 2011

Journal Articles

LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients

Hatice Duzkale, Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Alessandra Ferrajoli, Susan O'Brien, William G. Wierda, John Pfeifer, Tadeusz Majewski, Bogdan A. Czerniak, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Emil J Freireich, Michael J. Keating, Lynne V. Abruzzo

Blood (2011) 117 (15): 4076–4084.

https://doi.org/10.1182/blood-2010-09-304881

Published: 2011

Includes: Supplemental data

Journal Articles

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

Hagop Kantarjian, Farhad Ravandi, Susan O'Brien, Jorge Cortes, Stefan Faderl, Guillermo Garcia-Manero, Elias Jabbour, William Wierda, Tapan Kadia, Sherry Pierce, Jianqin Shan, Michael Keating, Emil J. Freireich

Blood (2010) 116 (22): 4422–4429.

https://doi.org/10.1182/blood-2010-03-276485

Published: 2010

Includes: Supplemental data

Journal Articles

Untreated Patients with Acute Myeloid Leukemia, Age 50–59 Years and Performance Status 2 Should Be as Eligible for Targeted Therapy as Older Patients.

Apostolia M. Tsimberidou, MD, PhD, Hagop M. Kantarjian, MD, Stefan Faderl, MD, Sherry Pierce, RN, Emil J. Freireich, MD, Elihu Estey, MD

Blood (2007) 110 (11): 2864.

https://doi.org/10.1182/blood.V110.11.2864.2864

Published: 2007

Journal Articles

Exclusion from Acute Myeloid Leukemia (AML) Clinical Trials of Patients Unlikely To Respond.

Apostolia-Maria Tsimberidou, MD, PhD, Hagop M. Kantarjian, MD, Stefan Faderl, MD, Emil J. Freireich, MD, Elihu Estey, MD

Blood (2007) 110 (11): 2867.

https://doi.org/10.1182/blood.V110.11.2867.2867

Published: 2007

Journal Articles

Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia

Ehab Atallah, Jorge Cortes, Susan O'Brien, Sherry Pierce, Mary Beth Rios, Elihu Estey, Maurie Markman, Michael Keating, Emil J. Freireich, Hagop Kantarjian

Blood (2007) 110 (10): 3547–3551.

https://doi.org/10.1182/blood-2007-06-095844

Published: 2007

Journal Articles

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Susan O’Brien, M.D., Peter McLaughlin, M.D., Sijin Wen, M.S., William Wierda, M.D., Ph.D., Hagop M. Kantarjian, M.D., John Manning, M.D., Susan Lerner, M.S., Mark Hess, B.B.A., Emil J. Freireich, M.D., Michael J. Keating, M.D.

Blood (2006) 108 (11): 2790.

https://doi.org/10.1182/blood.V108.11.2790.2790

Published: 2006

Journal Articles

A Prognostic Score for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Analysis of 2189 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John Manning, M.D., Susan Lerner, M.S., Mark A. Hess, Hagop Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.

Blood (2006) 108 (11): 2783.

https://doi.org/10.1182/blood.V108.11.2783.2783

Published: 2006

Journal Articles

Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Hagop M. Kantarjian, M.D., Michael J. Keating, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., Jorge Cortes, M.D., Francis Giles, M.D., Charles Asa Koller, M.D., Guillermo Garcia-Manero, M.D., Sherry Pierce, B.S.N., Mark Brandt, Emil J. Freireich, M.D., Elihu H. Estey, M.D.

Blood (2006) 108 (11): 802.

https://doi.org/10.1182/blood.V108.11.802.802

Published: 2006

Journal Articles

Genomic Aberrations in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Count: Analysis of 1694 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John T. Manning, M.D., Lynne V. Abruzzo, M.D., Ph.D., Susan Lerner, M.S., Mark A. Hess, B.B.A., Hagop M. Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.

Blood (2006) 108 (11): 4958.

https://doi.org/10.1182/blood.V108.11.4958.4958

Published: 2006

Journal Articles

Eradication of minimal residual disease in hairy cell leukemia

Farhad Ravandi, Jeffrey L. Jorgensen, Susan M. O'Brien, Srdan Verstovsek, Charles A. Koller, Stefan Faderl, Francis J. Giles, Alessandra Ferrajoli, William G. Wierda, Shirley Odinga, Xuelin Huang, Deborah A. Thomas, Emil J. Freireich, Dan Jones, Michael J. Keating, Hagop M. Kantarjian

Blood (2006) 107 (12): 4658–4662.

https://doi.org/10.1182/blood-2005-11-4590

Published: 2006

Journal Articles

Conception and Pregnancy in Patients (pts) with Chronic Myeloid Leukemia (CML) Receiving Therapy with Imatinib Mesylate (IM).

Pat Ault, APN, Hagop Kantarjian, MD, Susan O’Brien, MD, Charles Koller, MD, Stefan Faderl, MD, Emil J. Freireich, MD, Mary Beth Rios, R.N., Jorge Cortes, MD

Blood (2005) 106 (11): 1104.

https://doi.org/10.1182/blood.V106.11.1104.1104

Published: 2005

Journal Articles

Mechanisms of Increased Reactive Oxygen Species (ROS) Generation Induced by Organic Arsenic Derivative S-Dimethylarsino-Glutathione (SGLU; ZIO-101).

Xiaodong Cheng, MD, Manshouri Taghi, MS, BS, Peng Huang, MD, PhD, Mirna Golemovic, BS, Ralph Zingaro, PhD, Emil J. Freireich, MD, BS, Michael Andreeff, MD, PhD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD, PhD

Blood (2005) 106 (11): 4445.

https://doi.org/10.1182/blood.V106.11.4445.4445

Published: 2005

NARROW

Granulocyte Transfusions for Neutropenic Patients with Perirectal and Perineal Infections

Outcome of Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) By Age Group over 35 Years: A Single Institution Experience

Comparison of Two Apheresis Instruments (Old vs. New) for Granulocyte Collection: A Single Institutional Experience

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV- mutated chronic lymphocytic leukemia

Overall Survival in Hematopoietic Stem Cell Transplantation Is Not Correlated with Age of Red Cells Transfused Pre- and Post-Transplantation

A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy

Preventing Platelet Alloimmunization for Patients with Hematologic Malignancies: Rapid HLA-class I and HPA Immunogenetic Profiling to Enable Selection of Optimally Matched Platelets

Twenty-five years of peripheral blood stem cell transplantation

LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

Untreated Patients with Acute Myeloid Leukemia, Age 50–59 Years and Performance Status 2 Should Be as Eligible for Targeted Therapy as Older Patients.

Exclusion from Acute Myeloid Leukemia (AML) Clinical Trials of Patients Unlikely To Respond.

Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients.

A Prognostic Score for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Analysis of 2189 Patients.

Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients.

Genomic Aberrations in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Count: Analysis of 1694 Patients.

Eradication of minimal residual disease in hairy cell leukemia

Conception and Pregnancy in Patients (pts) with Chronic Myeloid Leukemia (CML) Receiving Therapy with Imatinib Mesylate (IM).

Mechanisms of Increased Reactive Oxygen Species (ROS) Generation Induced by Organic Arsenic Derivative S-Dimethylarsino-Glutathione (SGLU; ZIO-101).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only